Barbara L Melosky (Barb Melosky, Barbara Melosky, Barb L Melosky)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 41

Top Topics

Liver Metastases

Epidermal Growth Factor Receptor

Top Venues

Current oncology (Toronto, Ont.)

International journal of cancer

Therapeutic advances in medical oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara L Melosky, Mark D Vincent, Anna L McGuire, Anthony M Brade, Quincy Chu, Parneet Cheema, Ilidio Martins, Jonathan D Spicer, Stephanie Snow, Rosalyn A Juergens
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer. International journal of cancer 155 (6) (2024)
Barbara L Melosky, Mark D Vincent, Anna L McGuire, Anthony M Brade, Quincy Chu, Parneet Cheema, Ilidio Martins, Jonathan D Spicer, Stephanie Snow, Rosalyn A Juergens
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer. International journal of cancer 155 (6) (2024)
Julia R Naso, Stephen Yip, Curtis Hughesman, Barbara L Melosky, Tanner Dowhy, Melissa K McConechy, John C English, Penelope M A Brasher, James J Choi, Kyle Grant, John Yee, Stephen Lam, Anna McGuire
Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study. Current oncology (Toronto, Ont.) 31 (7) (2024)
Julia R Naso, Stephen Yip, Curtis Hughesman, Barbara L Melosky, Tanner Dowhy, Melissa K McConechy, John C English, Penelope M A Brasher, James J Choi, Kyle Grant, John Yee, Stephen Lam, Anna McGuire
Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study. Current oncology (Toronto, Ont.) 31 (7) (2024)
Julia R Naso, Stephen Yip, Curtis Hughesman, Barbara L Melosky, Tanner Dowhy, Melissa K McConechy, John C English, Penelope M A Brasher, James J Choi, Kyle Grant, John Yee, Stephen Lam, Anna McGuire
Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study. Current oncology (Toronto, Ont.) 31 (7) (2024)
Barbara L Melosky, Mark D Vincent, Anna L McGuire, Anthony M Brade, Quincy Chu, Parneet Cheema, Ilidio Martins, Jonathan D Spicer, Stephanie Snow, Rosalyn A Juergens
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer. International journal of cancer (2024)
Martin Rupp, Fiorella Fanton-Aita, Stephanie L Snow, Paul Wheatley-Price, Barbara L Melosky, Rosalyn A Juergens, Quincy Chu, Normand Blais, Shantanu O Banerji, Ryan Ng, Shoghag Khoudigian, Arushi Sharma, Phu Vinh On, Geoffrey Liu
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience. Current oncology (Toronto, Ont.) 30 (7) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
Barbara L Melosky, Natasha B Leighl, David E Dawe, Normand Blais, Paul F Wheatley-Price, Quincy S-C Chu, Rosalyn A Juergens, Peter M Ellis, Alexander Sun, Devin Schellenberg, Diana N Ionescu, Parneet K Cheema
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (7) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Marie-Hélène Denault, Jamie Feng, Shelley Kuang, Aria Shokoohi, Bonnie Leung, Mitchell Liu, Eric Berthelet, Janessa Laskin, Sophie Sun, Tina Zhang, Cheryl Ho, Barbara L Melosky
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression. Current oncology (Toronto, Ont.) 30 (8) (2023)
Ali Silver, Cheryl Ho, Qian Ye, Jianjun Zhang, Ian Janzen, Jessica Li, Montgomery Martin, Lang Wu, Ying Wang, Stephen Lam, Calum MacAulay, Barbara L Melosky, Ren Yuan
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years. Current oncology (Toronto, Ont.) 30 (6) (2023)
Ali Silver, Cheryl Ho, Qian Ye, Jianjun Zhang, Ian Janzen, Jessica Li, Montgomery Martin, Lang Wu, Ying Wang, Stephen Lam, Calum MacAulay, Barbara L Melosky, Ren Yuan
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years. Current oncology (Toronto, Ont.) 30 (6) (2023)
Kelly Li, Ian Bosdet, Stephen Yip, Cheryl Ho, Janessa Laskin, Barbara L Melosky, Ying Wang, Sophie Sun
Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (8) (2023)
Ali Silver, Cheryl Ho, Qian Ye, Jianjun Zhang, Ian Janzen, Jessica Li, Montgomery Martin, Lang Wu, Ying Wang, Stephen Lam, Calum MacAulay, Barbara L Melosky, Ren Yuan
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years. Current oncology (Toronto, Ont.) 30 (6) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Ali Silver, Cheryl Ho, Qian Ye, Jianjun Zhang, Ian Janzen, Jessica Li, Montgomery Martin, Lang Wu, Ying Wang, Stephen Lam, Calum MacAulay, Barbara L Melosky, Ren Yuan
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years. Current oncology (Toronto, Ont.) 30 (6) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
Parneet K Cheema, Shantanu O Banerji, Normand Blais, Quincy S-C Chu, Rosalyn A Juergens, Natasha B Leighl, Adrian Sacher, Brandon S Sheffield, Stephanie L Snow, Mark Vincent, Paul F Wheatley-Price, Stephen Yip, Barbara L Melosky
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC. Current oncology (Toronto, Ont.) 30 (7) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Anna L McGuire, Melissa K McConechy, Barbara L Melosky, John C English, James J Choi, Defen Peng, John Yee, Benjamin L S Furman, Rosalia Aguirre Hernandez, Pedro Feijao, David T Mulder, Curtis Hughesman, Stephen Yip
The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis. Current oncology (Toronto, Ont.) 29 (4) (2022)
Barbara L Melosky
Immunotherapy in Thoracic Malignancies: New Treatment and New Hope. Current oncology (Toronto, Ont.) 29 (2) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Chloe A Lim, Norbert Banyi, Tracy Tucker, Diana N Ionescu, Barbara L Melosky
A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib. Current oncology (Toronto, Ont.) 29 (2) (2022)
Doreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, Janessa J Laskin, Jason S Agulnik, Desiree Hao, Scott A Laurie, Jennifer H Law, Lisa W Le, Lesli A Kiedrowski, Barbara L Melosky, Frances A Shepherd, Victor Cohen, Paul Wheatley-Price, Rachel Vandermeer, Janice Juan Ning Li, Roxanne Fernandes, Aria Shokoohi, Richard B Lanman, Natasha B Leighl
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic advances in medical oncology 14 (2022)
Norbert Banyi, Deepu Alex, Curtis Hughesman, Kelly McNeil, Diana N Ionescu, Carmen Ma, Stephen Yip, Barbara L Melosky
Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform. Current oncology (Toronto, Ont.) 29 (10) (2022)
Diana N Ionescu, Tracy L Stockley, Shantanu O Banerji, Christian Couture, Cheryl A Mather, Zhaolin Xu, Normand Blais, Parneet K Cheema, Quincy S-C Chu, Barbara L Melosky, Natasha B Leighl
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 29 (7) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Barbara L Melosky, Parneet Cheema, Rosalyn A Juergens, Natasha B Leighl, Geoffrey Liu, Paul Wheatley-Price, Adrian Sacher, Stephanie Snow, Ming-Sound Tsao, Deanna McLeod, Quincy Siu-Chung Chu
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer. Therapeutic advances in medical oncology 13 (2021)
Edward S Kim, Barbara L Melosky, Keunchil Park, Nobuyuki Yamamoto, James C-H Yang
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations. Future oncology (London, England) 17 (18) (2021)
Yuti P Patel, Donald Husereau, Natasha B Leighl, Barbara L Melosky, Julian Nam
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients. Current oncology (Toronto, Ont.) 28 (6) (2021)
Barbara L Melosky, Karl-Otto Kambartel, Maik Haentschel, Margherita Bennetts, Dana J Nickens, Julia Brinkmann, Antonin Kayser, Michael Moran, Federico Cappuzzo
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis. Molecular diagnosis & therapy (2021)
Barbara L Melosky, Parneet K Cheema, Anthony Brade, Deanna McLeod, Geoffrey Liu, Paul Wheatley Price, Kevin Jao, Devin D Schellenberg, Rosalyn Juergens, Natasha Leighl, Quincy Chu
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer. The oncologist 25 (11) (2020)